医学
颈动脉内膜切除术
围手术期
冲程(发动机)
危险系数
内科学
心脏病学
比例危险模型
单变量分析
前瞻性队列研究
动脉内膜切除术
狭窄
外科
置信区间
多元分析
机械工程
工程类
作者
Henrietta Törmänen,Suvi Koskinen,Krista Nuotio,Pirkka Vikatmaa,Petri T. Kovanen,Lauri Soinne,Perttu J. Lindsberg,Petra Ijäs
摘要
Abstract Background and purpose Perioperative stroke is a well‐recognized complication of carotid endarterectomy (CEA), but well‐performing prediction models do not exist for it. Our aim was to identify novel predictors for perioperative ischaemic cerebrovascular events (iCVEs), emphasizing cerebrovascular imaging and potential biomarkers for stroke in carotid stenosis (CS) patients in a well‐characterized prospective CS cohort. Methods Helsinki Carotid Endarterectomy Study 2 is an observational prospective and consecutive cohort study of CS patients subjected to CEA during 2012–2015. The associations between perioperative stroke and transient ischaemic attack (iCVEs) and potential predictive factors were evaluated by univariate and Cox regression analyses. Results Of 488 operated CS patients, 33 (7%) sustained an iCVE including 21 (4%) ischaemic strokes. In univariate analysis, moderate ipsilateral CS (hazard ratio [HR] 2.14, 95% confidence interval [CI] 1.08–4.23), covert or chronic ipsilateral brain infarct in imaging (HR 2.27, 95% CI 1.09–4.76) and severe cerebral small vessel disease (HR 3.36, 95% CI 1.04–10.88) appeared as novel risk factors for perioperative iCVE. In Cox proportional hazards regression modelling, female gender (HR 3.03, 95% CI 1.30–7.04), a history of coronary heart disease (HR 3.59, 95% CI 1.52–8.47), covert or chronic ipsilateral infarct (HR 2.32, 95% CI 1.01–5.34) and severe small vessel disease (HR 2.63, 95% CI 1.07–6.47) were the strongest independent predictors of perioperative iCVE. Conclusions In addition to the previously reported clinical risk factors, it was found that imaging markers of past cerebrovascular disease, covert or chronic ipsilateral infarct and severe small vessel disease, and moderate ipsilateral stenosis are associated with perioperative iCVEs.
科研通智能强力驱动
Strongly Powered by AbleSci AI